• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tariffs

JNJ
Pharma

J&J's Joaquin Duato 'optimistic' amid MFN discussions with Trump

Comments from J&J’s chief executive suggest that the company is largely aligned with many of President Donald Trump’s policy goals.
Fraiser Kansteiner Oct 14, 2025 11:52am
MA strategy deal block push come together form

Germany's LTS boosts US drug delivery CDMO footprint through M&A

Oct 13, 2025 10:49am
Ypsomed

Ypsomed builds 1st facility in US, spending $248M for N.C. site

Oct 10, 2025 11:27am
Virginia

AZ breaks ground on $4.5B API production facility in Virginia

Oct 9, 2025 1:45pm
Biopharma biotech biotech industry biopharma industry science microscope DNA double helix

Regulatory, policy uncertainties harm biopharma planning: Cytiva

Oct 8, 2025 3:11pm
FDA

FDA drafts new policies to boost US drug production

Oct 3, 2025 3:52pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings